About AMN Life Science
AMN Life Science is a Healthcare company based in Mumbai (India) founded in 2003. It manufactures and markets pharmaceutical products internationally with over 300 formulations. It operates on a B2B model. The company has 331 employees. Its Indian entity Amn Life Science Private Limited reported revenue of ₹273 Cr. AMN Life Science offers products and services including Esomeprazole Capsules, Metronidazole Suspension, Amoxicillin Tablets, Paracetamol Suspension, and Metformin Tablets. Its focus areas include Pharmaceuticals, Formulations, Generic Drugs and Nutraceuticals. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
AMN Life Science is a pharmaceutical company based in Mumbai, India, that manufactures and markets a wide range of formulations for international markets, including South East Asia and Africa. It focuses on quality medicines at affordable prices, with products in categories like gastrointestinal and antibiotics. The company is WHO certified and operates as an export house, emphasizing global supply and accessibility through its product basket of over 300 items.
- Headquarters Mumbai, India
- Employees 331
- SectorsHealthcare
- Email••••••••
- Website amnlife.com
- Social X Facebook
- Legal Name Amn Life Science Private Limited
- Date of Incorporation 30 May, 2003
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹273 Cr
FY 2025 · +42% YoY
- Net Profit₹22.39 Cr
FY 2025 · 8% margin
- EBITDA₹43.73 Cr
FY 2025 · 16% margin
- Employee Count331
Associated legal entities of AMN Life Science
AMN Life Science is associated with 2 registered companies on The Company Check; the primary company is Amn Life Science Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amn Life Science Private Limited CIN U24230MH2003PTC140663 | Active | 30 May 2003 | Mumbai, Maharashtra | ₹273 Cr | 183 | 2 | View details |
| Amn Life Private Limited CIN U24100MH2020PTC343922 | Amalgamated | 17 Aug 2020 | Mumbai, Maharashtra | ₹46.3 Cr | 215 | 3 | View details |
Products & Services of AMN Life Science
AMN Life Science offers a comprehensive portfolio of products and services, including Esomeprazole Capsules, Metronidazole Suspension, Amoxicillin Tablets, Paracetamol Suspension, and Metformin Tablets.
Treats acid-related stomach conditions effectively
Antibacterial treatment for infections
Fights bacterial infections with clavulanic acid combination
Relieves pain and reduces fever in children
Manages blood sugar levels for diabetes patients
Board of directors of Amn Life Science Private Limited (AMN Life Science)
Amn Life Science Private Limited is the primary company behind AMN Life Science. The boards of the 2 registered companies of AMN Life Science currently have 3 directors; the longest-serving is Ashish Vijay Khemka, appointed in 2003. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Vijay Khemka DIN 00757815 | Managing Director | 30 May 2003 | 23 yrs 4 mo | Amn Life Science Private Limited, Amn Life Private Limited |
| Reshma Ashish Khemka DIN 01421931 | Director | 06 Feb 2006 | 20 yrs 8 mo | Amn Life Science Private Limited, Amn Life Private Limited |
| Ashish Hariprasad Sarawgi DIN 01855194 | Director | 19 Jan 2023 | 3 yrs 9 mo | Amn Life Private Limited |
People of AMN Life Science
1 people are tracked at AMN Life Science (1 in leadership); the tracked headcount is 331.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for AMN Life Science
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of AMN Life Science
Figures of Amn Life Science Private Limited, the primary company behind AMN Life Science, for FY 2025. Revenue was ₹273 Cr (+42% year on year). Net profit was ₹22.39 Cr (8% margin). EBITDA was ₹43.73 Cr (16% margin). Revenue has grown at a compounded annual rate of +17% over three years and +17% over five years.
- ₹273 CrRevenue · FY 2025 · +42% YoY
- ₹22.39 CrNet profit · 8% margin
- ₹43.73 CrEBITDA · 16% margin
- ₹4.00 CrPaid-up capital
- 183Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Amn Life Science Private Limited are on its company page.
Detailed financial statements for AMN Life Science
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to AMN Life Science
AMN Life Science has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of AMN Life Science
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AMN Life Science
AMN Life Science was founded in 2003.
AMN Life Science is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
AMN Life Science has 331 employees.
The primary company behind AMN Life Science, Amn Life Science Private Limited, reported revenue of ₹273 Cr for FY 2025, up 42% year on year.
AMN Life Science is a pharmaceutical company based in Mumbai, India, that manufactures and markets a wide range of formulations for international markets, including South East Asia and Africa. It focuses on quality medicines at affordable prices, with products in categories like gastrointestinal and antibiotics. The company is WHO certified and operates as an export house, emphasizing global supply and accessibility through its product basket of over 300 items.
AMN Life Science's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
AMN Life Science offers Esomeprazole Capsules, Metronidazole Suspension, Amoxicillin Tablets, Paracetamol Suspension, and Metformin Tablets.
AMN Life Science is associated with 2 legal entities: Amn Life Science Private Limited, Amn Life Private Limited.
The legal entities of AMN Life Science currently have 3 directors, including Reshma Ashish Khemka, Ashish Vijay Khemka, Ashish Hariprasad Sarawgi.